Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience

New subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your patients about these? Credit available for this activity expires: 7/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001272?ecd=bdc_podcast_libsyn_mscpedu